Sale!

Pharmacotherapeutics for Advanced Practice 3rd Edition Arcangelo Peterson Test Bank

$80.00 $12.99

Pharmacotherapeutics for Advanced Practice 3rd Edition Arcangelo Peterson Test Bank

ISBN-13: 978-1451111972

ISBN-10: 1451111975

 

Description

Pharmacotherapeutics for Advanced Practice 3rd Edition Arcangelo Peterson Test Bank

ISBN-13: 978-1451111972

ISBN-10: 1451111975

 

 

 

Be the best nurse you can be:

Nursing test banks are legit and very helpful. This test bank on this page can be downloaded immediately after you checkout today.

Here is the definition of nursing

Its true that you will receive the entire legit test bank for this book and it can happen today regardless if its day or night. We have made the process automatic for you so that you don’t have to wait.

We encourage you to purchase from only a trustworthy provider:

Our site is one of the most confidential websites on the internet. We maintain no logs and guarantee it. Our website is also encrypted with an SSL on the entire website which will show on your browser with a lock symbol. This means not a single person can view any information.

on Amazon, we do not sell the eBook for the , and we only sell the test bank that corresponds with the .

Have any comments or suggestions?

When you get your file today you will be able to open it on your device and start studying for your class right now.

Free Nursing Test Questions:

Chapter 56. Menopause and Menopausal Hormone Therapy

 

MULTIPLE CHOICE

 

  1. The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing:
A. Cardiovascular risk
B. Risk of stroke or other thromboembolic event
C. Breast cancer
D. Vasomotor symptoms

 

 

ANS:  D                    PTS:   1

 

  1. The optimal maximum time frame for hormone replacement therapy (HRT) or estrogen replacement therapy (ERT) is:
A. 2 years
B. 5 years
C. 10 years
D. 15 years

 

 

ANS:  B                    PTS:   1

 

  1. Dosage changes of conjugated equine estrogen (Premarin) are made at ____ intervals.
A. 1 to 2 week
B. 2 to 4 week
C. 6 to 8 week
D. 12 week

 

 

ANS:  C                    PTS:   1

 

  1. The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness is:
A. Ability to deliver higher doses of estrogen in a non-oral form
B. The vaginal cream formula provides moisture to the vaginal area
C. Relief of symptoms without increasing cardiovascular risk
D. All of the above

 

 

ANS:  C                    PTS:   1

 

  1. Women with an intact uterus should be treated with both estrogen and progestin due to:
A. Increased risk for endometrial cancer if estrogen alone is used
B. Combination therapy provides the best relief of menopausal vasomotor symptoms
C. Reduced risk for colon cancer with combined therapy
D. Lower risk of developing blood clots with combined therapy

 

 

ANS:  A                    PTS:   1

 

  1. Ongoing monitoring for women on estrogen replacement therapy (ERT) includes:
A. Lipid levels, repeated annually if abnormal
B. Annual health history and review of risk profile
C. Annual mammogram
D. All of the above

 

 

ANS:  D                    PTS:   1

 

  1. Kristine would like to start hormone replacement therapy (HRT) to treat the significant vasomotor symptoms she is experiencing during menopause. Education for a woman considering hormone replacement would include:
A. Explaining that HRT is totally safe if used short term
B. Telling her to ignore media hype regarding HRT
C. Discussing the advantages and risks of HRT
D. Encouraging the patient to use phytoestrogens with the HRT

 

 

ANS:  C                    PTS:   1

 

  1. Angela is a black woman who has heard that women of African descent do not need to worry about osteoporosis. What education would you provide Angela about her risk?
A. She is correct, black women do not have much risk of developing osteoporosis due to their dark skin
B. Black women are at risk of developing osteoporosis due to their lower calcium intake as a group
C. If she doesn’t drink alcohol, her risk of developing osteoporosis is low
D. If she has not lost more than 10% of her weight lately, her risk is low

 

 

ANS:  B                    PTS:   1

 

Reviews

There are no reviews yet.

Be the first to review “Pharmacotherapeutics for Advanced Practice 3rd Edition Arcangelo Peterson Test Bank”

Your email address will not be published. Required fields are marked *